As of close of business last night, Newmark Group Inc’s stock clocked out at $9.80, down -4.58% from its previous closing price of $10.27. On the day, 1162332 shares were traded. NMRK stock price reached its highest trading level at $10.37 during the session, while it also had its lowest trading level at $9.77.
Ratios:
To gain a deeper understanding of NMRK’s stock, we examine its different ratios. In the meantime, Its Debt-to-Equity ratio is 1.38 whereas as Long-Term Debt/Eq ratio is at 0.90.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Piper Sandler on December 20, 2023, Upgraded its rating to Overweight and sets its target price to $13 from $7 previously.
Goldman Downgraded its Neutral to Sell on December 12, 2022, while the target price for the stock was maintained at $8.
Valuation Measures:
As of this moment, Newmark’s Price-to-Earnings (P/E) ratio for their current fiscal year is 40.16, and their Forward P/E ratio for the next fiscal year is 7.42. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 4.02. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.69 while its Price-to-Book (P/B) ratio in mrq is 1.36.
Stock Price History:
Over the past 52 weeks, NMRK has reached a high of $11.51, while it has fallen to a 52-week low of $5.07.
Shares Statistics:
A total of 152.64M shares are outstanding, with a floating share count of 139.65M. Insiders hold about 19.12% of the company’s shares, while institutions hold 58.93% stake in the company.
Earnings Estimates
As of right now, Merck & Company, Inc. analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $38.87, with high estimates of $9.80 and low estimates of $11.19.
Analysts are recommending an EPS of between $Real Estate and $Healthcare for the fiscal current year, implying an average EPS of $Financial Services.
